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ABSTRAK 
Leptospirosis merupakan penyakit berjangkit yang semakin banyak dilaporkan 
di serata dunia. Simptom-simptom penyakit ini adalah tidak spesifik dan hampir 
menyerupai simptom jangkitan lain seperti deman denggi, malaria, hepatits dan 
deman kepialu, terutamanya di negara-negara tropika di mana penyakit-penyakit 
tersebut adalah endemik. Demam denggi pula adalah penyakit berjangkit yang 
dilihat sebagai krisis kesihatan awam disebabkan kadar jangkitan sedunia yang 
tinggi. Dalam laporan kes ini, kami melaporkan satu kes berkenaan seorang pesakit 
yang menghidapi demam denggi yang juga disahkan positif dengan jangkitan 
leptospirosis melalui ujian serologi. Koinfeksi antara demam denggi dan leptospirosis 
boleh menimbulkan kerumitan pada peringkat diagnosis kerana simptom-simptom 
bagi kedua-dua jangkitan tersebut hampir serupa. Oleh itu, pakar klinikal harus 
mempunyai indeks wasangka yang tinggi,khususnya di kawasan di mana kedua-dua 
penyakit ini adalah endemik. Penggunaan ujian diagnosis yang berasaskan antigen 
adalah amat penting bagi membantu pakar klinikal dalam membuat diagnosis yang 
tepat secepat mungkin agar rawatan yang sewajarnya dapat diberikan.
Kata kunci: koinfeksi, penyakit berjangkit, demam denggi, leptospirosis
ABSTRACT
Leptospirosis is an emerging infectious disease with worldwide distribution. Its 
symptoms may mimic a number of other infections such as dengue, malaria, 
hepatitis and typhoid fever, particularly in tropical countries where these diseases 
are endemic. Similarly, dengue is an important infectious disease that poses as a 
public health emergency due to its rapid epidemic spread across the world. Here, 
we report a fatal case of dengue fever in a patient who was also serologically 
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worldwide. According to WHO, 
the yearly incidence of leptospirosis 
ranges from 0.1–1.0/100,000 in 
temperate climates to 10–100/100,000 
in the humid tropics (World Health 
Organization 2003). In addition, the 
incidence may reach over 100 per 
100,000 during out breaks particularly 
in five high-exposure risk groups (World 
Health Organization 2003).
 The clinical manifestation of both 
infectious diseases at early stages of 
illness consists of an ample array of 
non-specific signs and symptoms 
such as high-grade fever, anorexia, 
generalised body ache, arthralgia, 
myalgia, nausea, and vomiting (Libraty 
et al. 2007; Flannery et al. 2001). Libraty 
et al. (2007) reported that the presence 
of petechial rash was significantly 
higher in dengue patients compared 
to those with leptospirosis. Another 
study conducted in Brazil by Flannery 
et al. (2001) showed that a greater 
proportion of patients develop jaundice 
in leptospirosis infection compared to 
those with dengue. However, both of 
the aforementioned symptoms present 
at the late stage of the diseases. Because 
their clinical manifestations at early 
stages are similar, it may complicate 
the diagnosis and management of such 
patients with acute fever. We report a 
positive for leptospirosis. Co-infection of both dengue and leptospirosis can lead 
to an illness with overlapping symptoms and therefore present a clinical diagnostic 
dilemma to the treating physician. Hence, a high index of suspicion among clinicians 
is required, especially in high endemic areas. The optimal usage of antigen-based 
rapid diagnostic tests is essential to aid the clinicians to make timely and accurate 
diagnosis as well as to start appropriate treatment regimes.
Keywords: co-infection, communicable diseases, dengue, leptospirosis
INTRODUCTION
Dengue and leptospirosis, commonly 
found in humid tropical and subtropical 
areas, are infectious diseases of global 
importance. Mixed infections of these 
two pathogens which are associated 
with high mortality, are typically seen 
in areas of high endemicity, especially 
in Malaysia. 
 Dengue is the fastest spreading 
vector-borne disease in the world that 
is transmitted by mosquitoes Aedes 
aegypti and Aedes albopictus. The 
incidence of dengue infection continues 
to rise with growing geographic 
expansion to new countries for the past 
half-century, and a 30-fold increase has 
been reported for that period (World 
Health Organization 2009). In fact, the 
number of reported cases in Malaysia 
has notably increased over the previous 
decade; from 32 cases per 100,000 to 
361 cases per 100,000 in 2014 (MOH 
2015). This mosquito-borne viral illness 
places 2.5 million people in more 
than 100 countries at risk with an 
annual estimation of 50 million cases 
of dengue infections occur worldwide 
(World Health Organization 2009).
 Leptospirosis is a bacterial  infection 
caused by the spirochete leptospiraceae 
and is the most common zoonosis 
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fatal case of a patient who presented 
with acute febrile illness (AFI) and was 
positive for dengue virus DENV-3 and 
leptospiral spp.
CASE REPORT
A 43-yrs-old farmer presented to 
a district hospital in Sarawak, East 
Malaysia with a history of high grade 
fever, generalised bodyache as well 
as haemoptysis for three days. He was 
previously well. He denied abdominal 
pain, nausea or vomiting. Neither 
chest discomfort nor shortness of 
breath was reported. The initial blood 
investigation showed leukopenia and 
thrombocytopenia, which prompted 
his referral to the nearest tertiary centre 
for further management.
 On examination, the patient was 
conscious and orientated with good 
hydration status. His blood pressure was 
107/59 mmHg and the pulse rate was 
85 beat/min which was regular and of 
good volume. He was not tachypnoeic 
with a respiratory rate of 20 breaths/
min. Documented temperature in the 
Emergency Department was 39.9°°C. 
Examination of the abdomen showed 
enlarged liver 3 cm below the right 
costal margin with neither tenderness 
nor guarding. In addition, there was 
no jaundice or rash. Other systemic 
examinations were unremarkable.
 Repeated blood investigations 
showed bicytopenia with deranged 
renal and liver function tests (Table 
1). The initial chest radiograph was 
normal. The diagnosis of dengue fever 
with warning signs was initially made 
based on his presenting features and 
a positive dengue NS-1 antigen test. 
The patient’s serum was also tested 
for dengue specific IgM antibodies 
using enzyme-linked immunosorbent 
assay (ELISA) which came out to 
be positive. He was managed with 
appropriate supportive therapy and 
hydration with crystalloid fluids 
according to the established guidelines 
for dengue. However, four hours later, 
his condition drastically deteriorated. 
He developed fulminant pulmonary 
haemorrhage which required invasive 
ventilation. Intravenous (IV) Ceftriaxone 
was promptly started based on strong 
clinical suspicion of leptospirosis 
despite pending confirmatory serology. 
The leptospirosis IgM rapid test was 
then reported to be positive and was 
further confirmed with a positive 
microscopic agglutination test (MAT) as 
shown in Table 1. Reverse transcriptase 
polymerase  chain reaction (RT-PCR) 
was also performed and dengue virus 
type 3 (DENV-3) infection was identified.
 Throughout his admission in the 
intensive care unit, his condition 
did not improve  despite aggressive 
medical regimes as well as escalation 
of antibiotics. Ventilation became 
increasingly difficult and required high 
ventilator settings due to persistent 
pulmonary haemorrhage with Type 
ll respiratory failure and was further 
compounded by ventilator-acquired 
pneumonia. There was worsening of 
diffuse opacity over bilateral lung fields, 
as evidenced in the serial chest X-rays 
in Figure 1. In addition to that, severe 
thrombocytopenia persisted despite 
multiple blood product transfusions 
(Table 1). On day 23 of hospital 
admission, the patient, unfortunately, 
succumbed to death.
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Table 1: Laboratory results on the first, seventh, fourteenth and twenty-first day of 
hospitalization, respectively.
Laboratory Results Day 1 Day 4 Day 17 Day21
Haemoglobin (g/dL) 16.1 10.9 9.3 9.5
White cell count (x 109/L) 1.8 4.46 5.8 3.57
Platelet (x 109/L) 6 50 42 30
Haemotocrit (%) 44.7 34.2 30 31
Urea (mmol/L) 9.4 7.8 8.5 12
Creatinine (umol/L) 131 71 62 97
Total bilirubin (mg/dL) 7 38 19
Alanine aminotransferase (U/L) 214 374 93
Aspartate aminotransferase (U/L) 73 565 120
Albumin 41 35 27
Dengue NS-1 Antigen Positive
Dengue IgM  (ELISA) Positive
Dengue RT-PCR DENV-3
Figure 1: Serial chest radiographs throughout hospital admission. Chest radiograph taken at Day 2 
(A) showed bilateral perihilar haziness. Serial chest radiographs were taken at Day 5 (B), Day 8( C), 
Day 16 (D), Day 21 (E) and Day 22 (F) showed worsening opacities over both lung fields.
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DISCUSSION
Both dengue and leptospirosis are 
among the many medical conditions 
that cause AFI in humid tropical 
and subtropical areas. Because the 
clinical manifestations are similar, both 
dengue and leptospirosis are often 
indistinguishable at the early stages of 
illness. Hence, this can complicate the 
diagnosis of a patient presented with 
AFI especially in high  endemic  areas. 
In addition, co-infection cases are not 
uncommon. A study conducted in 
Jamaica showed that 2.5% of the 314 
dengue IgM positive samples were 
also positive for leptospirosis infection 
(Brown et al. 2010). In another study 
conducted by Kumar et al. (2012), co-
infection of dengue and leptospirosis 
was confirmed in 1.3% of 1,309 cases 
where both dengue and leptospirosis 
were investigated. Similar report is also 
found in a study done in India by with 
result of mixed infection of leptospirosis 
and dengue at 17.5% (Deodar & John 
2011).
 Our patient was initially presented 
with symptoms of viral-like illness 
with evidence of bleeding tendency. 
The positive dengue NS-1 antigen 
result together with leucopenia, 
thrombocytopenia and raised 
haematocrit level prompted us to treat 
him as dengue fever with warning signs 
as he came from a high endemic area 
for dengue. It is a common practice that 
if a patient with acute fever is confirmed 
to be dengue positive, dengue infection 
is assumed as the sole cause of the 
fever. Such assumption has caused 
leptospirosis, “The Great Mimicker”, to 
be overlooked and under-diagnosed. 
Due to the overlapping symptoms and 
signs, it remains difficult to diagnose 
without serologic test and this problem 
is proven in a recent cross-sectional 
study conducted among 10 healthcare 
facilities done in Northeastern Malaysia. 
Only 31% of confirmed leptospirosis 
cases were diagnosed as leptospirosis 
at the time of hospital discharge while 
another 38% were wrongly diagnosed 
as dengue fever or dengue hemorrhagic 
fever (Rafizah et al. 2012). A study in 
Thailand by Libraty et al. (2007) also 
reported that 19% of the children 
with confirmed leptospirosis were not 
diagnosed correctly on discharge from 
hospital. Because the specific treatment 
differs for both infectious diseases, the 
availability of antigen-based rapid 
diagnostic tests is essential to aid the 
clinicians to make timely and accurate 
diagnosis as well as to start appropriate 
treatment regimes, which is even more 
important in co-infection cases.
 The mechanisms causing the 
increased vascular permeability in 
severe dengue are not well defined 
yet. Many theories have been 
postulated about the pathogenesis 
of severe dengue infection. Among 
all, the most studied one is about the 
development of imbalance immune 
response. Expression of cytokine, 
chemokines, and adhesion molecules 
as well activation of T-lymphocytes and 
complement system are responsible 
for the endothelial dysfunction 
(World Health Organization 2009). 
In addition, dengue virus infection 
can affect megakaryocytopoieses, 
leading to platelet dysfunction and 
thrombocytopenia (World Health 
Organization 2009). Similarly, 
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the development of endothelial 
dysfunction in severe leptospirosis is 
due to activation of immune mediators 
(Maciel et al. 2006; Yang & Hsu 2005). 
Hence, in our case, we believe that the 
synergistic actions of both organisms 
lead to generalized endothelial damage, 
thrombocytopenia as well as platelet 
dysfunction, resulting in fulminant 
pulmonary haemorrhage. Mixed 
infection of dengue and leptospirosis is 
associated with a higher mortality rate 
as reported by Kumar et al. (2012) The 
mortality rate was reported at 29.6% 
(5/17) in co-infected cases, followed by 
leptospirosis 14.6% (42/287) and dengue 
3.7% (9/239). Sharma et al. (2012)  also 
reported  that  highest  mortality  of 
12.69%  (5/63)  in  co-infected  cases 
followed  by leptospirosis 1.91% (27/63) 
and dengue 0.425% (6/63).
 Co-infection with dengue and 
leptospirosis requires a variation of 
treatment modalities. Transfusion of 
blood products such as fresh packed red 
cells or fresh whole blood is mandatory 
in severe dengue with haemorrhagic 
complication (World Health 
Organization 2009). To date, the use 
of antibiotics in leptospirosis remains 
controversial. However, a Cochrane 
systemic review showed that antibiotic 
treatment might shorten the duration 
of illness (Brett-Major & Coldren 2012). 
Few studies have advocated the use 
of glucocorticoids in haemorrhagic 
pulmonary leptospirosis (Trivedi et al. 
2001; Ittyachen et al. 2005; Shenoy et 
al. 2006). The role of glucocorticoids 
is imminently significant, particularly 
within the first 12 hrs of respiratory 
involvement (Shenoy et al. 2006). 
It reduces the need for mechanical 
ventilation and the mortality rate in 
severe leptospirosis (Shenoy et al. 2006; 
Kularatne et al. 2011). In addition, other 
immunomodulation approaches such 
as plasmapheresis and immunoglobulin 
may also be helpful (Meaudre et al. 
2008). Some novel approaches such 
as desmopressin, inhaled nitric oxide, 
activated Protein C and activated Factor 
VII were also proven beneficial in 
severe leptospirosis when conventional 
therapy ceases to work (Gulati & Gulati 
2008). However, the potential of such 
treatments in co-infection with dengue 
and leptospirosis still remain unclear.
CONCLUSION
Infection of dengue and leptospirosis 
may co-exist, especially in high 
endemic areas. Hence, a high index 
of suspicion is necessary to diagnose 
a co-infection as most clinicians are 
used to linking every symptom and 
sign to a single pathology.  In addition, 
the optimal usage of rapid diagnostic 
laboratory investigation plays a crucial 
role in determining the management 
of undifferentiated AFI, particularly in 
mixed infection cases. Co-infection 
with dengue and leptospirosis, as 
depicted in the case report, warrants 
a variation of treatment regimes that 
has to be initiated the earliest possible 
in order to reduce its severity and, 
ultimately leading to the favourable 
outcome of this condition.
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